Stone L M, Kahn S E, Deeb S S, Fujimoto W Y, Porte D
Division of Metabolism, Endocrinology, University of Washington, Seattle.
Diabetes Care. 1994 Dec;17(12):1480-3. doi: 10.2337/diacare.17.12.1480.
To determine if sequence variants in the glucokinase (GCK) gene contribute to the high risk of impaired glucose metabolism in Japanese-Americans and whether the gene sequence differs between Japanese-Americans and Caucasians.
Forty-seven unrelated Japanese-Americans with one or more first-degree relatives with non-insulin-dependent diabetes mellitus (NIDDM) were selected, irrespective of glucose tolerance status. By World Health Organization criteria, 13 had normal glucose tolerance, 11 had impaired glucose tolerance, and 23 had NIDDM. Variations in the GCK gene were identified by single-strand conformation polymorphism analysis and sequenced using standard techniques.
Six variants of the GCK gene were identified in a total of 21 subjects: 1) a G--> A substitution at nucleotide -30 in the beta-cell-specific promoter; 2) an A--> G substitution at nucleotide 244 in the 5'-untranslated region (5'-UTR) of exon 1a; 3) a C--> G substitution at nucleotide 403 in the 5'-UTR of exon 1a; 4) a G--> A variant 13 base pair (bp) 5' to the intron 3 exon 4 junction; 5) a silent substitution in the third base of codon 145 in exon 4; and 6) a C--> T substitution 8 bp 3' to the exon 9 intron 9 junction. None of these variations would be expected to affect the structure of the GCK enzyme. While none of these variants were significantly associated with IGT or NIDDM, a nonsignificant increase in the beta-cell promoter variant was observed in subjects with abnormal glucose tolerance. No uniform sequence differences in the GCK gene were identified between Japanese-American and Caucasian-American subjects.
Mutations affecting the amino acid sequence of GCK do not account for the increased incidence of impaired glucose metabolism in Japanese-Americans, and the gene sequence does not uniformly differ from that in Caucasians.
确定葡萄糖激酶(GCK)基因中的序列变异是否导致日裔美国人葡萄糖代谢受损风险增加,以及该基因序列在日裔美国人和高加索人之间是否存在差异。
选择47名有一名或多名非胰岛素依赖型糖尿病(NIDDM)一级亲属的无亲缘关系的日裔美国人,无论其糖耐量状态如何。根据世界卫生组织标准,13人糖耐量正常,11人糖耐量受损,23人患有NIDDM。通过单链构象多态性分析鉴定GCK基因的变异,并使用标准技术进行测序。
在总共21名受试者中鉴定出GCK基因的6种变异:1)β细胞特异性启动子中核苷酸-30处的G→A替换;2)外显子1a的5'非翻译区(5'-UTR)中核苷酸244处的A→G替换;3)外显子1a的5'-UTR中核苷酸403处的C→G替换;4)内含子3外显子4连接处5'端13个碱基对(bp)处的G→A变异;5)外显子4中密码子145第三个碱基的沉默替换;6)外显子9内含子9连接处3'端8 bp处的C→T替换。预计这些变异均不会影响GCK酶的结构。虽然这些变异均与糖耐量受损(IGT)或NIDDM无显著相关性,但在糖耐量异常的受试者中观察到β细胞启动子变异有非显著增加。在日裔美国人和高加索裔美国受试者之间未发现GCK基因的一致序列差异。
影响GCK氨基酸序列的突变不能解释日裔美国人葡萄糖代谢受损发生率的增加,且该基因序列与高加索人相比并无一致差异。